NASDAQ · Drug Manufacturers - Specialty & Generic

INDV (INDV) Stock

$34.56 -1.06% NASDAQ: INDV Healthcare

Valuation

MetricValue
Price$34.56
Market Cap$4.31B
P/E Ratio12.61
P/B Ratio-21.59
P/S Ratio3.36
EPS (TTM)$1.64
52-Week High$42.81
52-Week Low$22.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-216.13%
ROA28.79%
ROCE141.92%
Gross Margin83.11%
Operating Margin33.31%
Net Margin26.65%
Debt/Equity-2.45
Current Ratio0.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$791.0M$901.0M$1.1B$1.2B$1.2B
Operating Profit$213.0M$-81.0M$-156.0M$32.0M$265.0M
Net Profit$205.0M$-44.0M$-129.0M$2.0M$210.0M
EPS$1.31$-0.37$-0.91$0.02$1.64
Op Margin26.9%-9.0%-14.3%2.7%21.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$1.8B$1.8B$1.3B$1.2B
Total Liabilities$1.6B$1.7B$2.0B$1.7B$1.3B
Cash$1.1B$778.0M$316.0M$319.0M$195.0M
Borrowings$286.0M$277.0M$283.0M$375.0M$351.0M

Latest News

Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV) Simply Wall St. · Jun 30, 2026 ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome Zacks · Jun 29, 2026 Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable Zacks · Jun 29, 2026 Bull of the Day: Neurocrine Biosciences (NBIX) Zacks · Jun 29, 2026 IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati Zacks · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$353.0M$-4.0M$-300.0M$36.0M$-27.0M
Investing Cash Flow$-48.0M$-227.0M$-148.0M$38.0M$-133.0M
Financing Cash Flow$-109.0M$-90.0M$-33.0M$-175.0M$-10.0M
Net Cash Flow$244.0M$-328.0M$-458.0M$3.0M$-124.0M
Free Cash Flow$319.0M$-9.0M$-353.0M$5.0M$-94.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA11.01
FCF Yield-2.48%
Quick Ratio0.66
Interest Coverage19.19
Return 1Y46.02%
Return 3Y53.27%
Return 5Y166.99%

Ownership

Insiders Held1.98%
Institutions Held108.89%
Institutions Float Held111.09%
Institutional HolderSharesReport Date
Blackrock Inc.18,542,2202026-03-31
Vanguard Portfolio Management LLC7,891,8192026-03-31
Oaktree Capital Management LP6,984,1022026-03-31
Vanguard Capital Management LLC5,586,5762026-03-31
State Street Corporation4,903,9932026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACAD $28.89 -0.07% 8.94 $4.95B 0.00%
ADMA $9.33 -0.64% 12.17 $2.16B 0.00%
AMRX $17.68 +1.20% 36.56 $5.65B 0.00%
CRNX $84.95 +0.00% -16.80 $9.00B 0.00%
HNGE $90.02 -2.74% -13.65 $6.97B 0.00%

About INDV

INDV stock trades at $34.56 with a market capitalization of $4.31B. The stock is valued at a price-to-earnings (P/E) ratio of 12.61, price-to-book of -21.59, price-to-sales of 3.36. Over the past 52 weeks the stock has ranged between $22.22 and $42.81, and currently trades 19.3% below its 52-week high.

On profitability, INDV generates a return on equity (ROE) of -216.13%, return on capital employed of 141.92%, an operating margin of 33.31%, a net profit margin of 26.65%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides